ORIMERE Trademark

Trademark Overview

On Monday, October 21, 2019, a trademark application was filed for ORIMERE with the United States Patent and Trademark Office. The USPTO has given the ORIMERE trademark a serial number of 88661844. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by AbbVie Inc.. The ORIMERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
orimere

General Information

Serial Number88661844
Word MarkORIMERE
Filing DateMonday, October 21, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 5, 2022SOU EXTENSION 5 FILED
Thursday, October 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 5, 2022TEAS EXTENSION RECEIVED
Friday, March 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022SOU EXTENSION 4 GRANTED
Wednesday, March 23, 2022SOU EXTENSION 4 FILED
Wednesday, March 23, 2022TEAS EXTENSION RECEIVED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 3 FILED
Wednesday, October 20, 2021TEAS EXTENSION RECEIVED
Friday, April 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 21, 2021SOU EXTENSION 2 FILED
Wednesday, April 21, 2021TEAS EXTENSION RECEIVED
Friday, October 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 14, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 14, 2020SOU EXTENSION 1 FILED
Wednesday, October 14, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 27, 2020ASSIGNED TO EXAMINER
Thursday, October 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

orimere gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related